Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

Z. Li; F. Stölzel; K. Onel; M. Sukhanova; M. K. Mirza; K. L. Yap; O. Borinets; R. A. Larson; W. Stock; M. M. Sasaki; L. Joseph; G. Raca

doi:10.1038/leu.2015.81

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

Z. Li^*, F. Stölzel, K. Onel, M. Sukhanova, M. K. Mirza, K. L. Yap, O. Borinets, R. A. Larson, W. Stock, M. M. Sasaki, L. Joseph, G. Raca

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Letter › peer-review

36 Scopus citations

Original language	English (US)
Pages (from-to)	2113-2116
Number of pages	4
Journal	Leukemia
Volume	29
Issue number	10
DOIs	https://doi.org/10.1038/leu.2015.81
State	Published - Oct 1 2015

Funding

This work was funded by the American Cancer Society Institutional Research Grant (#IRG-58-004) and the University of Chicago Comprehensive Cancer Center Support Grant (#P30 CA14599). Contra el Cáncer (GCB120981SAN), Spain. The study was also supported internationally by the International Myeloma Foundation Junior Grant Proposal and the Multiple Myeloma Research Foundation research fellow award.

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2015.81

Cite this

@article{66e8be0bcce342ecb9a453ce7f013163,

title = "Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma",

author = "Z. Li and F. St{\"o}lzel and K. Onel and M. Sukhanova and Mirza, {M. K.} and Yap, {K. L.} and O. Borinets and Larson, {R. A.} and W. Stock and Sasaki, {M. M.} and L. Joseph and G. Raca",

note = "Funding Information: This work was funded by the American Cancer Society Institutional Research Grant (#IRG-58-004) and the University of Chicago Comprehensive Cancer Center Support Grant (#P30 CA14599). Funding Information: Contra el C{\'a}ncer (GCB120981SAN), Spain. The study was also supported internationally by the International Myeloma Foundation Junior Grant Proposal and the Multiple Myeloma Research Foundation research fellow award.",

year = "2015",

month = oct,

day = "1",

doi = "10.1038/leu.2015.81",

language = "English (US)",

volume = "29",

pages = "2113--2116",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

AU - Li, Z.

AU - Stölzel, F.

AU - Onel, K.

AU - Sukhanova, M.

AU - Mirza, M. K.

AU - Yap, K. L.

AU - Borinets, O.

AU - Larson, R. A.

AU - Stock, W.

AU - Sasaki, M. M.

AU - Joseph, L.

AU - Raca, G.

N1 - Funding Information: This work was funded by the American Cancer Society Institutional Research Grant (#IRG-58-004) and the University of Chicago Comprehensive Cancer Center Support Grant (#P30 CA14599). Funding Information: Contra el Cáncer (GCB120981SAN), Spain. The study was also supported internationally by the International Myeloma Foundation Junior Grant Proposal and the Multiple Myeloma Research Foundation research fellow award.

PY - 2015/10/1

Y1 - 2015/10/1

UR - http://www.scopus.com/inward/record.url?scp=84943587079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943587079&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.81

DO - 10.1038/leu.2015.81

M3 - Letter

C2 - 25787914

AN - SCOPUS:84943587079

SN - 0887-6924

VL - 29

SP - 2113

EP - 2116

JO - Leukemia

JF - Leukemia

IS - 10

ER -

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this